Optimind Pharma (XCNQ:OMND) EPS (Basic): C$0.00 (TTM As of Nov. 2025)


What is Optimind Pharma EPS (Basic)?

Optimind Pharma XCNQ:OMND EPS (Basic) is C$0.00 as of Nov. 2025. The stock has 1 warning sign investors should review.

Optimind Pharma's basic earnings per share (Basic EPS) for the three months ended in Nov. 2025 was C$0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Nov. 2025 was C$0.00.

Optimind Pharma's EPS (Diluted) for the three months ended in Nov. 2025 was C$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Nov. 2025 was C$0.00.

Optimind Pharma's EPS without NRI for the three months ended in Nov. 2025 was C$0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Nov. 2025 was 0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Optimind Pharma  (XCNQ:OMND) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Optimind Pharma EPS (Basic) Related Terms

Optimind Pharma EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Optimind Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Optimind Pharma EPS (Basic) Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23 Feb24 Feb25
EPS (Basic)
0.00 -0.04 -0.01 -0.00

Optimind Pharma Quarterly Data
Jun21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Optimind Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Optimind Pharma's Basic EPS for the fiscal year that ended in Feb. 2025 is calculated as

Basic EPS (A: Feb. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.216-0)/111.454
=-0.00

Optimind Pharma's Basic EPS for the quarter that ended in Nov. 2025 is calculated as

Basic EPS (Q: Nov. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.029-0)/103.148
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of C$0.00 mean?
Optimind Pharma (XCNQ:OMND) has a EPS (Basic) of C$0.00 as of Nov. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Optimind Pharma and its competitors.
Is Optimind Pharma's EPS (Basic) too high?
Optimind Pharma's current EPS (Basic) is C$0.00.
How does Optimind Pharma's EPS (Basic) compare to ZTS?
Optimind Pharma's EPS (Basic) of C$0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Optimind Pharma and its competitors. Optimind Pharma's current EPS (Basic) is C$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimind Pharma stock overvalued right now?
Optimind Pharma (XCNQ:OMND) has a current EPS (Basic) of C$0.00. The current EPS (Basic) is C$0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Optimind Pharma (XCNQ:OMND), the current EPS (Basic) is C$0.00 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Optimind Pharma Business Description

Address 40 King Street W, Suite 2400, Scotia Plaza, Toronto, ON, CAN, M5H 3Y2
Optimind Pharma Corp, through its clinic, specializes in prescribing medical cannabis and other alternative treatments for various medical ailments. It offers psychedelic-like therapies at its clinic, helping people suffering from PTSD, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted treatment and other psychedelic-enhanced psychotherapy modalities. The company is also partnered with developers of psilocybin-associated treatments and products to further expand its treatment and program offerings.